Protein therapeutics refer to the use of proteins as therapeutic agents to treat a wide range of medical conditions and diseases. Unlike conventional small-molecule drugs, protein therapeutics are larger and more complex molecules that mimic or regulate natural biological processes in the body. These proteins can be naturally occurring or engineered using advanced biotechnological methods.

The market is witnessing strong growth due to the increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders. The rising adoption of biologics, advancements in biotechnology, and growing demand for targeted therapies are significantly driving market expansion.

👉 Get sample market research report copy now@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2035

The global protein therapeutics market was valued at US$ 318.4 Bn in 2022 and is projected to grow at a CAGR of 6.3% from 2023 to 2031, reaching more than US$ 549.4 Bn by the end of 2031. Market growth is driven by the increasing incidence of chronic diseases, advancements in biotechnology, and growing demand for biosimilars and personalized medicine.

Analysis of Key Players in the Protein Therapeutics Market

The global protein therapeutics market is fragmented, with a large number of international and regional players competing through innovation, partnerships, and research investments.

Key companies operating in the market include:

• Thermo Fisher Scientific, Inc.
  · Genzyme Corporation (Sanofi)
  · AbbVie, Inc.
  · Sanofi
  · Leadiant Biosciences
  · Takeda Pharmaceutical Company Limited
  · Amicus Therapeutics
  · Bayer AG
  · Bristol-Myers Squibb
  · Daiichi Sankyo Company
  · Abbott
  · Other Prominent Players

These companies are focusing on strategic collaborations, acquisitions, and investments in biologics and biosimilars to strengthen their market position and expand therapeutic offerings.

Key Developments in Global Protein Therapeutics Industry

• In January 2022, Thermo Fisher Scientific, Inc. completed the acquisition of PeproTech, a leading provider of recombinant proteins, for a total cash purchase price of US$ 1.85 Bn. PeproTech, based in Cranbury, New Jersey, is a privately held provider of bioscience reagents, including cytokines and growth factors, used in the development and manufacturing of cell and gene therapies and broader cell culture applications. The acquisition will enable Thermo Fisher to provide customers significant benefits through an integrated offering.
• In April 2022, Plexium and AbbVie partnered to develop and commercialize targeted protein degradation (TPD) therapeutics for neurological conditions. The collaboration combines AbbVie’s neuroscience expertise with Plexium’s comprehensive TPD platform, which enables the discovery of novel therapies toward historically challenging drug targets. The partnership aims to strengthen Plexium’s leadership position in TPD and broaden its best-in-class capabilities into neurological diseases. The collaboration will involve preclinical research activities for collaboration targets, with AbbVie selecting programs for additional research and development.

Analysts’ Viewpoint on the Global Protein Therapeutics Market

Industry analysts highlight that the increasing prevalence of chronic diseases and rising demand for innovative biologic therapies are key drivers of the protein therapeutics market. Monoclonal antibodies, recombinant proteins, and biosimilars are transforming treatment approaches across oncology, autoimmune diseases, and metabolic disorders.

Advancements in biotechnology and genetic engineering have enabled large-scale production of therapeutic proteins while overcoming challenges associated with natural protein sourcing. In addition, the growing biosimilars market is improving affordability and accessibility of biologic therapies globally.

North America dominates the market due to its advanced biopharmaceutical infrastructure, strong regulatory support, and high R&D investments, while Asia Pacific is emerging as a high-growth region driven by expanding healthcare infrastructure and increasing focus on biopharmaceutical innovation.

👉 Discuss Implications for Your Industry or Do you want customize Report, Please Request Sample Research Report PDF@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2035

Key Player Strategies

⚙️ Product Innovation
Development of advanced biologics, monoclonal antibodies, and biosimilars

🌐 Strategic Collaborations
Partnerships and acquisitions to expand therapeutic capabilities

🏥 Expansion of Biopharmaceutical Manufacturing
Increasing production capacity for protein-based therapies

🔬 R&D Investments
Focus on protein engineering and personalized medicine

🌍 Global Market Expansion
Targeting emerging healthcare and biologics markets

Challenges

• High development and manufacturing costs of biologics
• Complex regulatory approval pathways
• Limited accessibility in low-income regions
• Storage and stability challenges for protein-based drugs

Opportunities

⚡ Rising Demand for Personalized Medicine
Growing focus on targeted therapies based on genetic profiles

🌱 Expansion of Biosimilars Market
Increasing affordability and accessibility of biologic therapies

🏥 Increasing Prevalence of Chronic Diseases
Growing need for advanced therapeutic solutions

🔬 Advancements in Biotechnology
Improved protein engineering and formulation technologies

🌍 Emerging Healthcare Markets
Rising healthcare investments in Asia Pacific and Latin America

Market Segmentation

By Product

• Monoclonal Antibodies
  • Insulin
  • Fusion Proteins
  • Erythropoietin
  • Interferons
  • Human Growth Hormone
  • Follicle Stimulating Hormone
  • Others

By Application

• Cancer
  • Metabolic Disorders
  • Immunologic Disorders
  • Hematological Disorders
  • Hormonal Disorders
  • Genetic Disorders
  • Others

By End-user

• Hospitals
  • Specialty Clinics
  • Research Institutes
  • Ambulatory Care Centers

By Region

• North America – Advanced biopharmaceutical ecosystem
  • Europe – Strong regulatory and research framework
  • Asia Pacific – Rapid healthcare and biologics expansion
  • Latin America
  • Middle East & Africa

Regional Outlook

North America dominates the protein therapeutics market due to strong technological advancements, increasing chronic disease prevalence, and a well-established biopharmaceutical sector. The U.S. leads the region with major pharmaceutical companies, research institutions, and proactive regulatory support for biologics and protein-based therapies.

Asia Pacific is witnessing rapid market growth driven by increasing healthcare infrastructure, rising chronic disease burden, and growing investments in biotechnology and pharmaceutical R&D. Countries such as China, India, Japan, and South Korea are significantly contributing to market expansion.

Europe also maintains a strong position due to ongoing biologics research and supportive healthcare systems, while Latin America and the Middle East & Africa are gradually emerging with improved healthcare access and biologics adoption.

Why Invest in the Protein Therapeutics Market Outlook 2031

✅ Strong market growth driven by rising chronic disease prevalence

✅ Increasing demand for biologics and targeted therapies

✅ Expanding biosimilars market improving treatment accessibility

✅ Rapid advancements in biotechnology and protein engineering

✅ Growing investments in personalized medicine and R&D

👉 To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=2035&ltype=S

FAQs

1. What is the projected market size by 2031?
   The market is expected to exceed US$ 549.4 Bn by 2031.
2. What is the CAGR of the market?
   The market is projected to grow at a CAGR of 6.3% from 2023 to 2031.
3. What factors are driving market growth?
   Increasing chronic diseases, advancements in biotechnology, and growth of biosimilars are major drivers.
4. Which region dominates the market?
   North America dominates due to advanced healthcare infrastructure and strong biopharmaceutical presence.
5. What are key trends in the market?
   Growth of monoclonal antibodies, personalized medicine, and biosimilars development are major market trends.

More Trending Reports by Transparency Market Research –

Sepsis Therapeutics Market: https://www.transparencymarketresearch.com/sepsis-therapeutics-market.html

Radiodermatitis Market: https://www.transparencymarketresearch.com/radiodermatitis-market.html

Anti-Inflammatory Therapeutics Market: https://www.transparencymarketresearch.com/anti-inflammatory-therapeutics-market.html

South America Equine Supplement Market: https://www.transparencymarketresearch.com/south-america-equine-supplement-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media Contact: 

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY – 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Sales Inquiries: sales@transparencymarketresearch.com
Media Inquiries: media@transparencymarketresearch.com